What Diseases and Conditions Are Similar to ALS?

Several dozen diseases and conditions can look like ALS, and some of them are treatable or even curable. ALS itself is defined by the progressive loss of motor neurons, but because motor neurons control so many body functions, anything that damages them or the nerves near them can produce overlapping symptoms: muscle weakness, twitching, wasting, difficulty speaking or swallowing. The critical difference is that some of these look-alikes respond to treatment, while ALS currently does not. That makes telling them apart one of the most consequential diagnostic challenges in neurology.

What ALS Actually Looks Like

ALS involves both upper motor neurons, which run from the brain down the spinal cord, and lower motor neurons, which run from the spinal cord out to the muscles. When both are failing at once, the combination of symptoms is distinctive: stiff, spastic limbs (upper motor neuron damage) alongside muscle wasting and twitching (lower motor neuron damage). Most conditions that mimic ALS affect only one of those two systems, so a neurologist’s first question is usually whether the signs truly involve both levels.

The picture gets more complicated because ALS itself comes in several forms. The “classical” presentation involves simultaneous upper and lower motor neuron damage, but atypical variants exist. Primary lateral sclerosis (PLS) predominantly affects upper motor neurons, causing stiffness and slow movement without much muscle wasting early on. Progressive muscular atrophy (PMA) does the opposite, targeting lower motor neurons and causing weakness and wasting without obvious stiffness. Progressive bulbar palsy (PBP) starts in the muscles of speech and swallowing. All of these are now widely considered to sit on the ALS spectrum rather than being separate diseases.

ALS Variants That Blur the Boundaries

A person diagnosed with PLS, PMA, or PBP will understandably wonder whether they “really” have ALS. The clinical reality is that most of these patients eventually develop the full picture. A study of nearly a thousand patients with PMA found that although they tended to survive longer than people with classical ALS, the disease was relentlessly progressive, and upper motor neuron involvement often appeared over time. The researchers concluded that PMA should be considered a form of ALS.¹ Similarly, research on progressive bulbar palsy found that roughly nine out of ten patients eventually progressed to definite ALS regardless of their initial presentation.²

Primary lateral sclerosis holds a slightly different place. Because it progresses more slowly, a confident PLS diagnosis is harder to make early. A Dutch study found that a PLS diagnosis should be deferred until at least four years after symptoms begin, because shorter durations correlated with higher rates of conversion to full ALS and shorter survival.³ For patients and families, the practical takeaway is that these variant diagnoses do not mean “not ALS.” They usually describe a specific pattern of ALS that started in one part of the motor system before spreading.

Genetic Motor Neuron Diseases

Two inherited conditions destroy motor neurons in ways that can closely resemble ALS, especially early in their course.

Kennedy disease (also called spinal and bulbar muscular atrophy) is an X-linked condition that affects adult men. It is caused by a trinucleotide repeat expansion in the androgen receptor gene and produces progressive limb and bulbar muscle weakness that can look strikingly similar to ALS.⁴ The critical difference is pace and pattern. Kennedy disease progresses much more slowly, and it includes features ALS does not: breast tissue enlargement, reduced fertility, and sensory nerve involvement. A study comparing the two conditions found that tongue atrophy and facial twitching appeared in all Kennedy disease patients early on, and sensory nerve testing showed markedly reduced nerve responses compared to ALS patients, providing a useful diagnostic clue.⁵ When a man presents with slowly progressive weakness and any hint of sensory loss or hormonal changes, genetic testing for Kennedy disease is warranted.

Spinal muscular atrophy (SMA) also destroys motor neurons, though it is usually diagnosed in childhood. The adult-onset form can occasionally raise the question of ALS. Research comparing the two diseases has shown that while both target the same neuromuscular connections, the mechanisms of damage differ. In ALS, the nerve side of the connection deteriorates first and early, whereas in SMA, damage to both the nerve and muscle sides appears at the same time.⁶ From a patient’s perspective, the biggest difference is practical: SMA now has approved gene-targeted therapies, making it one of the rare motor neuron diseases with disease-modifying treatment.

Autoimmune Conditions That Look Like ALS

This category matters the most for patients, because autoimmune mimics are often treatable. A correct diagnosis can mean the difference between progressive decline and meaningful recovery.

Multifocal motor neuropathy (MMN) is the most important ALS mimic in this group. It causes asymmetric weakness, usually starting in the hands and arms, with visible muscle wasting. To a clinician examining the patient, this looks a great deal like ALS. The disease is immune-mediated, frequently associated with antibodies against a nerve surface molecule called GM1, and its hallmark is conduction block on nerve conduction studies, meaning electrical signals get stuck partway along a nerve.⁷ About 80 percent of MMN patients respond to intravenous immunoglobulin therapy, which makes identifying this condition urgent. ALS is far more common than MMN, and the overlap in symptoms means some patients with MMN are initially misdiagnosed with ALS and told nothing can be done.

Myasthenia gravis (MG), particularly forms involving muscle-specific kinase (MuSK) antibodies, can also mimic ALS. MuSK myasthenia tends to hit the bulbar muscles hard, causing difficulty speaking and swallowing along with muscle atrophy, which is the same cluster of symptoms seen in bulbar-onset ALS.⁸ Case reports document patients initially diagnosed with motor neuron disease who turned out to have myasthenia gravis. One report described a man whose exaggerated reflexes, a classic upper motor neuron sign, helped steer clinicians toward a motor neuron disease diagnosis when in fact he had bulbar-onset myasthenia gravis.⁹ The authors emphasized that myasthenia gravis should remain on the list of possibilities for anyone presenting with unexplained bulbar symptoms, because it is treatable with immunotherapy.

Other immune-mediated neuropathies can round out this picture. Anti-GD1a motor neuropathy, for instance, can present with progressive weakness and abnormal electrical findings on nerve testing that look convincingly like ALS. One case series described an elderly woman with progressive weakness over eighteen months whose nerve studies showed changes typical of motor neuron disease, but who ultimately responded to immunoglobulin therapy and achieved remission after further treatment.¹⁰

Cervical Spine Problems and Other Structural Mimics

Cervical spondylotic myelopathy, where arthritis in the neck compresses the spinal cord, is one of the more common ALS imitators. It can produce weakness, stiffness, and wasting in the arms and hands along with brisk reflexes in the legs, a pattern that overlaps heavily with ALS.¹¹ Making matters harder, many people in the age group where ALS appears also have some degree of cervical spine degeneration, so both conditions can coexist. One approach that helps separate them involves recording muscle responses to brain stimulation. In ALS, the abnormal responses show up in muscles controlled by nerves above the neck (like the trapezius), whereas in cervical myelopathy those responses tend to be normal, since the problem is below the point where the trapezius nerve branches off. A study found that trapezius responses were abnormal in all ALS patients tested but normal in most cervical myelopathy patients.¹²

Hirayama disease is a much rarer structural mimic. It tends to affect young men and causes wasting in the hand and forearm muscles of one arm, which can look like the early stages of upper-limb ALS. The cause is thought to involve compression of the spinal cord during neck flexion. Unlike ALS, Hirayama disease typically stabilizes on its own after a few years.¹³

Metabolic and Endocrine Causes

Some conditions that mimic ALS are startlingly simple to fix once identified. Hyperparathyroidism, which causes elevated calcium in the blood, can produce weakness, twitching, and muscle wasting that closely resemble ALS. One published case described a patient whose motor neuron disease diagnosis was overturned when blood tests revealed high calcium from an overactive parathyroid gland. After surgery to remove the abnormal gland, the patient’s symptoms resolved.¹⁴ The authors recommended screening calcium levels in any patient presenting with a neurological disorder resembling ALS.

Whether elevated calcium actually causes motor neuron damage or just produces symptoms that happen to overlap remains debated. Earlier research noted that an association between hyperparathyroidism and ALS had been observed, but a causal relationship had not been confirmed.¹⁵ The practical message is straightforward: basic blood chemistry should be part of any ALS workup, because catching a metabolic cause early can prevent irreversible damage.

The ALS-Frontotemporal Dementia Spectrum

ALS is often thought of as a purely motor disease, but cognitive and behavioral changes occur in a substantial fraction of patients. Research has shown shared pathological and genetic markers between ALS and frontotemporal dementia (FTD), leading to the concept of an ALS-FTD spectrum.¹⁶ Revised diagnostic criteria now formally recognize this overlap as ALS-frontotemporal spectrum disorder (ALS-FTSD), reflecting the understanding that cognitive deficits in ALS fall along a continuum rather than being an all-or-nothing phenomenon.¹⁷

For families, this overlap creates confusion in both directions. A person developing behavioral changes and language difficulties may be diagnosed with FTD and only later develop the motor symptoms that reveal ALS. Conversely, a person with known ALS may develop personality changes or language problems that the family attributes to depression or frustration but that actually represent frontotemporal involvement. Neuroimaging research has found that ALS patients with cognitive or behavioral impairment show both structural brain changes similar to those in pure ALS and additional functional brain reorganization, supporting the idea that cognitive involvement represents a variant of the same disease process rather than a consequence of worsening motor disease.¹⁸

Post-Polio Syndrome and Viral Aftermaths

People who survived paralytic polio decades ago sometimes develop new weakness later in life, a condition called post-polio syndrome. Because it involves progressive motor neuron dysfunction, the symptoms can look similar to ALS. In someone with a polio history who begins losing strength after years of stability, clinicians face the question of whether this is post-polio syndrome (slow, self-limiting decline in previously affected motor neurons) or true ALS (rapidly progressive degeneration of motor neurons throughout the body).

Case reports have documented both scenarios. One described a patient with childhood polio who developed respiratory failure decades later, and the clinical team had to weigh whether this represented post-polio respiratory decline or ALS onset.¹⁹ Another report described a former polio patient whose neurological exam revealed both upper and lower motor neuron signs, features more consistent with ALS than with post-polio syndrome alone.²⁰ The distinction matters because post-polio syndrome progresses much more slowly and does not carry the same prognosis.

Paraneoplastic Motor Neuron Syndromes

Rarely, cancer can trigger the immune system to attack motor neurons, producing a syndrome that looks and tests like ALS on initial evaluation. One case report described a man presenting with arm weakness and fasciculations whose nerve studies showed an active neurogenic disorder consistent with motor neuron disease. He was ultimately found to have renal cell carcinoma, and the motor neuron syndrome was paraneoplastic, meaning it was driven by the body’s immune response to the cancer.²¹ Paraneoplastic motor syndromes are rare enough that screening every ALS patient for hidden cancer is not standard, but they become a consideration when the clinical picture has atypical features: unexplained weight loss, unusually rapid onset, or improvement with immunotherapy.

Heavy Metals and Toxic Exposures

Environmental exposures have long been investigated as possible contributors to ALS, and certain toxins can produce motor neuron symptoms on their own. Laboratory research has shown that lead, mercury, and tin compounds trigger a specific kind of protein clumping (involving TDP-43, a protein central to ALS pathology) in nerve cells.²² Chronic heavy metal poisoning can produce weakness, wasting, and fasciculations that raise the question of ALS. Lead neuropathy, for instance, classically causes wrist drop and hand weakness. When a patient with occupational or environmental heavy metal exposure develops motor symptoms, testing blood and urine metal levels is an important step before settling on an ALS diagnosis, because removing the exposure can halt or reverse the damage.

How Doctors Tell These Conditions Apart

Diagnosing ALS remains a clinical exercise. There is no single blood test or scan that confirms it. Instead, clinicians rely on the pattern of symptoms, electrical studies of nerves and muscles, brain and spinal imaging, and extensive testing to rule out mimics. The process often takes months, which is agonizing for patients but necessary to avoid a devastating misdiagnosis.

One emerging tool that may help speed up this process involves measuring neurofilament proteins, structural components of nerve cells that spill into spinal fluid and blood when neurons are damaged. Studies have found that ALS patients have significantly higher levels of these proteins in both spinal fluid and blood compared to patients with mimic conditions like neuropathies, myelopathies, and myopathies. When researchers compared ALS patients to patients with ALS mimics using these markers, the tests performed well at distinguishing the two groups, with accuracy in the range of 80 to 87 percent depending on which specific marker was measured.²³ That is not perfect enough to serve as a standalone diagnostic, but as part of the broader clinical picture, elevated neurofilament levels can increase a clinician’s confidence in an ALS diagnosis or prompt further investigation of alternatives when levels are unexpectedly low.

Why Misdiagnosis Happens and What It Costs

The conditions above represent a diagnostic minefield. ALS itself has no definitive biomarker, the mimics are individually rare (making them easy to overlook), and many clinicians outside specialized neuromuscular centers encounter few ALS patients in their careers. Delays in ALS diagnosis can result in compromised disease management and unnecessary costs.²⁴ The delay works in both directions: people with ALS who are told they have something treatable lose precious time for care planning, while people with a treatable condition who are told they have ALS endure unnecessary despair and may not receive the therapy that could help them.

Data from an ALS referral center in São Paulo illustrated the downstream consequences, finding that patients faced delayed diagnoses and showed patterns suggesting missed timely interventions such as assisted ventilation and nutritional support.²⁵ For anyone experiencing progressive weakness, fasciculations, or difficulty speaking and swallowing, referral to a neuromuscular specialist and thorough workup is not just advisable but can be life-altering. The list of things that look like ALS is long, and several of the entries on that list are conditions that modern medicine can treat.